Sfoglia per AUTORE
ROSSI F
Collezione AOU Novara
Items : 13
Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy. in HemaSphere / Hemasphere. 2022 Nov 11;6(12):e798. doi: 10.1097/HS9.0000000000000798. eCollection 2022 Dec.
2022
AOU Novara
Gherlinzoni F; Minoia C; Rossi FG; Lucchini E; Pennese E; Dessi' D; Ferrarini I; Scalzulli PR; Salerno M; Musso M; Nizzoli ME; Flenghi L; Masia F; Tisi MC; Bruna R; Puccini B; Fabbri A; Pellegrini C; Broccoli A; Argnani L; Musto P; Patti C; Stefoni V; Zinzani PL;
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. in American journal of hematology / Am J Hematol. 2021 May 1;96(5):E168-E171. doi: 10.1002/ajh.26127. Epub 2021 Feb 24.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Gentile M; Gattei V; Foà R; Ferrarini M; Polliack A; Gaidano G; Trentin L; Cuneo A; Fronza G; Cutrona G; Rossi D; Di Raimondo F; Neri A; Bomben R; Biagi A; Del Giudice I; Angeletti I; Galimberti S; Rago A; Caracciolo D; Cassin R; D'Arrigo G; Mendicino F; Botta C; Martino EA; Vigna E; Zucchetto A; Rossi FM; Scortechini I; et alii...
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study. in Leukemia / Leukemia. 2021 Jan;35(1):235-238. doi: 10.1038/s41375-020-0833-x. Epub 2020 Apr 14.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Sportoletti P; Laurenti L; Gattei V; Gaidano G; Polliack A; Foà R; Rossi D; Cuneo A; Di Raimondo F; Rigolin GM; Bomben R; Biagi A; Del Giudice I; Angeletti I; Rago A; Arrigo G; Vigna E; Botta C; Tripepi G; Fraticelli V; Zucchetto A; Scortechini I; Loseto G; Consoli U; Rossi FM; Pietrasanta D; Murru R; Chiarenza A; Condoluci A; et alii...
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E306-E310. doi: 10.1002/ajh.26235. Epub 2021 May 25.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Gentile M; Gattei V; Ferrarini M; Foà R; Polliack A; Trentin L; Cuneo A; Gaidano G; Di Raimondo F; Rossi D; Olivieri J; Jaksic O; Bomben R; Neri A; Fronza G; Rago A; Angeletti I; Cutrona G; Del Giudice I; Biagi A; Galimberti S; D'Arrigo G; Al-Janazreh H; Martino EA; Vigna E; Tripepi G; Zucchetto A; Rossi FM; Recchia AG; et alii...
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E269-E272. doi: 10.1002/ajh.26201. Epub 2021 May 3.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
D Arrigo G; Murru R; Gentile M; Gattei V; Polliack A; Trentin L; Gaidano G; Di Raimondo F; Cuneo A; Cutrona G; Rossi D; Menichini P; Olivieri J; Fronza G; Monti P; Del Giudice I; Bomben R; Neri A; Angeletti I; Biagi A; Rago A; Martino EA; Cassin R; Galimberti S; Foà R; Ferrarini M; Scortechini I; Rossi FM; Zucchetto A; et alii...
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases. in European journal of haematology / Eur J Haematol. 2021 Apr;106(4):493-499. doi: 10.1111/ejh.13573. Epub 2021 Jan 28.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Gentile M; Gattei V; Ferrarini M; Foà R; Trentin L; Polliack A; Gaidano G; Cuneo A; Di Raimondo F; Rossi D; Jaksic O; Monti P; Cutrona G; Bomben R; Neri A; Fronza G; Menichini P; Biagi A; Del Giudice I; Angeletti I; Rago A; Galimberti S; Cassin R; D'Arrigo G; Mendicino F; Martino EA; Vigna E; Al-Janazreh H; Zucchetto A; et alii...
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab. in Blood cancer journal / Blood Cancer J. 2020 Sep 16;10(9):92. doi: 10.1038/s41408-020-00358-3.
2020
AOU Città della Salute di Torino
AO Cuneo
AO Alessandria
AOU Novara
Gattei V; Morabito F; Ferrarini M; Gaidano G; Cuneo A; Foà R; Trentin L; Fronza G; Cutrona G; Di Raimondo F; Angeletti I; Bomben R; Neri A; D'Arrigo G; Tripepi G; Vitale C; Al-Janazreh H; Rossi FM; Zucchetto A; Scortechini I; Consoli U; Loseto G; Pietrasanta D; Bossio S; Moia R; Recchia AG; Lucia E; Mendicino F; Vigna E; et alii...
Bedside surgery in the newborn infants: survey of the Italian society of pediatric surgery. in Italian journal of pediatrics / Ital J Pediatr. 2020 Sep 16;46(1):134. doi: 10.1186/s13052-020-00889-2.
2020
AO Alessandria
AOU Novara
Rossi F; Pini Prato A; Paradies G; Piazza G; Papparella A; Nobili M; Midrio P; Licciardi F; Leva E; Lelli Chiesa P; Inserra A; Noccioli B; Messina M; Martino A; Mattioli G; Gentilino V; Gamba P; Federici S; Falchetti D; Esposito C; Del Rossi C; De Luca U; Dall' Oglio L; Cozzi DA; Clemente E; Cimador M; Ciardini E; Chiarenza F; Cheli M; et alii...
Improving standard of pediatric surgical care in a low resource setting: the key role of academic partnership. in Italian journal of pediatrics / Ital J Pediatr. 2020 Jun 9;46(1):80. doi: 10.1186/s13052-020-00827-2.
2020
AOU Novara
Lelli Chiesa P; Osman OTM; Aloi A; Andriani M; Benigni A; Catucci C; Giambelli P; Lisi G; Nugud FM; Presutti P; Prussiani V; Racalbuto V; Rossi F; Santoponte G; Turchetta B; Salman DEYM; Chiarelli F; Calisti A;
Feasibility of a Standardized Management for Primary Spontaneous Pneumothorax in Children and Adolescents: A Retrospective Multicenter Study and Review of the Literature. in Journal of laparoendoscopic & advanced surgical techniques. Part A / J Laparoendosc Adv Surg Tech A. 2020 Jul;30(7):841-846. doi: 10.1089/lap.2019.0493. Epub 2020 Apr 27
2020
AOU Novara
Cerchia E; Conighi ML; Bleve C; Chiarenza SF; Sgrò A; Pini Prato A; Rotundi F; Parolini F; Bulotta AL; Alberti D; Rena O; Rapuzzi G; Rossi F; La Canna F; Cheli M;
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.
2020
AOU Città della Salute di Torino
AOU Novara
Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; Forconi F; Mauro FR; Giudice ID; Peroni D; Kodipad AA; Jabangwe C; Sagiraju S; et alii...
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease. in British journal of haematology / Br J Haematol. 2019 Apr;185(1):156-159. doi: 10.1111/bjh.15405. Epub 2018 May 22.
2019
AOU Novara
Raponi S; Del Giudice I; Ilari C; Cafforio L; Messina M; Cappelli LV; Bonina S; Piciocchi A; Marinelli M; Peragine N; Mariglia P; Mauro FR; Rigolin GM; Rossi F; Bomben R; Dal Bo M; Del Poeta G; Diop F; Favini C; Rossi D; Gaidano G; Cuneo A; Gattei V; Guarini A; Foá R;
A cross-sectional nationwide survey on esophageal atresia and tracheoesophageal fistula. in Journal of pediatric surgery / J Pediatr Surg. 2015 Sep;50(9):1441-56. doi: 10.1016/j.jpedsurg.2015.01.004. Epub 2015 Jan 16.
2015
AOU Città della Salute di Torino
AOU Novara
Rossi F; Mattioli G; Piazza G; Ubertazzi M; De Grazia E; Licciardi S; Di Benedetto V; Cacciaguerra S; Mascia L; Lelli Chiesa PL; Clemente E; Esposito C; Romeo C; Aceti MG; Bartoli F; Salerno D; Liotta L; Rizzo A; Messina M; Cozzi D; Caterino S; Appignani A; Briganti V; Martino A; Chiarenza FS; Camoglio FS; Andermarcher M; Perrino G; Codrich D; et alii...